OCUL — OCULAR THERAPEUTIX INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in OCULAR THERAPEUTIX INC (OCUL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.72% (2025 Q4)
Avg. % of fund
1.35%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 418,080 +329,100 +369.9% 2.72% $5.1M $12.14
2025 Q2 ADDED 88,980 +46,683 +110.4% 0.98% $826K $9.28
2025 Q1 INITIATED 42,297 — — 0.37% $310K $7.33
% of Fund (quarterly)    OCUL price (monthly, adj. close)

Other funds also holding OCUL

As of 2025 Q4 — sorted by position size

SUMMER ROAD LLC 3Y 7Y 97.92% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 8.68% DELTEC ASSET MANAGEMENT LLC 3Y 7Y 5.0% VR Adviser, LLC 3Y 4.39% Octagon Capital Advisors LP 3Y 3.87% Saturn V Capital Management LP 3Y 3.35% Knoll Capital Management, LLC 3Y 7Y 3.34% Logos Global Management LP 3Y 2.57% Opaleye Management Inc. 3Y 7Y 2.55% TCG Crossover Management, LLC 3Y 2.31%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings